Jan 09, 2023 / 11:00PM GMT
Tessa Thomas Romero - JPMorgan Chase & Co, Research Division - Associate
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior Biotech Analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team. Our next presenting company is Pacira BioSciences. And speaking on behalf of the company, we have CEO, Dave Stack.
Before I turn it over to Dave, I just wanted to highlight to those listeners that we do have an Ask a Question button, where you could submit your question and I will try and get it in our discussion in 20 minutes or so here or you can raise your hand and ask it free form, so.
But with that, Dave, over to you.
David M. Stack - Pacira BioSciences, Inc. - Chairman & CEO
Thank you, Tessa, and thanks to JPMorgan for having the opportunity to spend a few minutes with you folks today. So, Pacira is the leading company in non-opioid pain management and our mission is to provide an opioid alternative to as many patients as possible. To achieve that
Pacira Biosciences Inc at JPMorgan Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers